Manju Aron, MD

Professor of Clinical Pathology and Urology

GU Service Line Director

Image of Manju Aron, MD
Is this your profile? Click to edit

Publications

  • Unintended consequences of legacy oversight in digital medicine. Nat Med. 2026 Jul; 32(7):2335-2337.. View in PubMed
  • Partial gland ablation for radio-recurrent prostate cancer: Short-term oncological and functional outcomes. Urol Oncol. 2026 Jul; 44(7):391-399.. View in PubMed
  • Clinicopathologic characterization of renal tumors with Folliculin (FLCN) biallelic inactivation. Virchows Arch. 2026 May 21.. View in PubMed
  • Pain Perception During Transperineal and Transrectal Prostate Biopsy Under Local An-esthesia: a Prospective Analysis of a Multi-ethnic and Diverse Cohort. Int Braz J Urol. 2026 May-Jun; 52(3).. View in PubMed
  • Immunohistochemical Expression of p63 and GATA3 in Lymphomas of the Urinary Bladder: A Clinicopathologic Study of a Potential Diagnostic Pitfall. Int J Surg Pathol. 2026 Sep; 34(6):1483-1488.. View in PubMed
  • Clinical and Molecular Characterization of Clear Cell Adenocarcinoma of the Urinary Tract: A Multi-Institutional Study. Am J Surg Pathol. 2026 Jun 01; 50(6):589-598.. View in PubMed
  • A transparent, lightweight and sustainable Green Learning AI model for prostate cancer detection on MRI. BJU Int. 2026 06; 137(6):1014-1025.. View in PubMed
  • Gene-body DNA methylation of ONECUT2 predicts its expression and prostate cancer aggressiveness in needle biopsies. Biomark Res. 2026 Jan 16; 14(1):18.. View in PubMed
  • Multiphase CT-Based Tumor and Peritumoral Radiomics for Characterization of Clear Cell Renal Cell Carcinoma. J Imaging Inform Med. 2026 Jan 05.. View in PubMed
  • Impact of magnetic resonance imaging visibility of prostate cancer on partial gland ablation. BJUI Compass. 2025 Aug; 6(8):e70065.. View in PubMed